(Q39107407)

23 February 2018

title

Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 Blockade (English)

1 reference

23 February 2018

4

Bulent Arman Aksoy

1 reference

23 February 2018

Jedd D. Wolchok

9

object named as

Jedd D Wolchok

1 reference

23 February 2018

author name string

Tavi Nathanson

1

1 reference

23 February 2018

Arun Ahuja

2

1 reference

23 February 2018

Alexander Rubinsteyn

3

1 reference

23 February 2018

Matthew D Hellmann

5

1 reference

23 February 2018

Diana Miao

6

1 reference

23 February 2018

Eliezer Van Allen

7

1 reference

23 February 2018

Taha Merghoub

8

1 reference

23 February 2018

Alexandra Snyder

10

1 reference

23 February 2018

Jeff Hammerbacher

11

1 reference

23 February 2018

publication date

12 December 2016

1 reference

23 February 2018

Cancer Immunology Research

published in

1 reference

23 February 2018

volume

5

1 reference

23 February 2018

issue

1

1 reference

23 February 2018

page(s)

84-91

1 reference

23 February 2018

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

Structural interplay between germline interactions and adaptive recognition determines the bandwidth of TCR-peptide-MHC cross-reactivity.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

Genomic Classification of Cutaneous Melanoma

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

Nivolumab and ipilimumab versus ipilimumab in untreated melanoma

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

Pembrolizumab for the treatment of non-small-cell lung cancer

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

Robust enumeration of cell subsets from tissue expression profiles

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

PD-1 blockade induces responses by inhibiting adaptive immune resistance

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

Genetic basis for clinical response to CTLA-4 blockade in melanoma

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

15 June 2018

UV signature mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

Deconstructing the Peptide-MHC Specificity of T Cell Recognition

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

Virus-specific CD4(+) memory-phenotype T cells are abundant in unexposed adults.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

Prediction of protein-destabilizing polymorphisms by manual curation with protein structure

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

Type I interferon is selectively required by dendritic cells for immune rejection of tumors

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

Gene signature in melanoma associated with clinical activity: a potential clue to unlock cancer immunotherapy

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

Derivation of an amino acid similarity matrix for peptide: MHC binding and its application as a Bayesian prior

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

The immune epitope database 2.0.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

Identification of common molecular subsequences

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

Getting personal with neoantigen-based therapeutic cancer vaccines

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

Molecular signatures database (MSigDB) 3.0.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

An immune-active tumor microenvironment favors clinical response to ipilimumab

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5253347

Caveats and pitfalls of ROC analysis in clinical microarray research (and how to avoid them)

4 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27956380

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27956380

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/2326-6066.CIR-16-0019

1 reference

23 February 2018

PMCID

5253347

1 reference

23 February 2018

PubMed ID

27956380

1 reference

23 February 2018